Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle Gel

NCT03115476 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03115476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03115476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle Gel
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Terminated
Start date
June 16, 2017
Completion date
March 12, 2018
Enrollment
563 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis, squamous cell carcinoma